CIBC lowers OpenText's price target to $37, citing softer guidance and a watchful stance on the company's planned divestiture of non-core assets to sharpen its AI focus.
Warren Buffett once admitted that managing a smaller pool of capital can be a 'huge structural advantage.' For retail investors, this isn't just theory—it's a practical edge in accessing high-growth opportunities that are now out of reach for the investing giant.
As the U.S. Treasury prepares its quarterly debt issuance update, bond dealers are on high alert for any shift in strategy aimed at managing soaring yields. While major changes are seen as unlikely, the administration's broader financial interventions have markets questioning the long-held "regular and predictable" borrowing mantra.
A new mandatory scheme requires all UK fuel stations to report price changes within 30 minutes, with data fed to comparison apps. The government-backed initiative aims to boost competition and save households an estimated £40 annually.
The Walt Disney Company exceeded Wall Street expectations in its fiscal first quarter, delivering robust results across its entertainment, experiences, and streaming divisions as longtime CEO Bob Iger prepares to hand over the reins later this year.
After a historic surge, gold prices have experienced their steepest drop in decades. Yet, analysts point to enduring geopolitical tensions and monetary policy shifts as reasons why the metal's long-term appeal remains intact.
While stocks priced between $10 and $50 can appear to offer an attractive balance of accessibility and maturity, not all are sound investments. We examine three companies in this range whose valuations and business prospects raise significant red flags for discerning investors.
While posting profits today, some companies face significant headwinds that threaten their long-term viability. We examine three such firms whose business models or market positions may be unsustainable, despite their current financials.
The all-stock deal creates a top-tier independent producer focused on the Permian Basin, with Beth McDonald at the helm aiming to unlock significant synergies and shareholder returns.
The Walt Disney Company reported a 5% rise in fiscal first-quarter revenue to $26 billion, fueled by its theme parks and streaming services. However, operating profit fell 9% as challenges in its traditional TV business and rising costs offset gains.
Precious metals extended their sharp decline following President Trump's nomination for the next Federal Reserve chair, a move markets interpret as locking in higher interest rates and boosting the U.S. dollar's appeal.
Essar Oil and Gas Exploration & Production (EOGEPL) is injecting $100 million into its flagship Raniganj East CBM block in West Bengal, aiming to scale up domestic natural gas production and explore shale potential in a bid to reduce India's import reliance.
A hefty cash reserve is typically a corporate strength, but for some companies, it signals stagnation rather than security. We examine three firms—Box, C3.ai, and Novavax—where significant net cash positions fail to offset concerns over growth prospects and valuation.
As e-commerce reshapes retail, some traditional consumer stocks struggle to keep pace. We examine three companies where valuation concerns and shifting market dynamics signal potential risk for investors.
The business services sector has mirrored the broader market's gains, but a wave of AI-driven disruption is separating the resilient from the vulnerable. We analyze one stock facing headwinds and two with the fundamentals to potentially thrive.
As economic uncertainty weighs on consumer spending, discretionary stocks have lagged the broader market. We examine three companies—TEGNA, Sabre, and Compass—whose business models and valuations raise significant questions for investors in the current climate.
While large-cap stocks dominate markets with their scale, some industry titans are struggling to find new avenues for expansion. We examine three household names where valuation concerns and growth constraints signal potential underperformance.
While investors chase AI and big tech, a niche biotech firm focused on rare genetic obesity disorders has quietly delivered staggering returns, with Wall Street seeing further 40% upside. Rhythm Pharmaceuticals' targeted approach and upcoming catalysts have analysts bullish, despite its relative anonymity.
The world's largest cryptocurrency exchange has initiated the conversion of its user protection fund to Bitcoin, starting with a $100 million on-chain transfer. The move signals a strategic shift towards native crypto assets for safeguarding client funds.
BeOne Medicines extends its collaboration with quantitative systems pharmacology firm InSysBio, aiming to optimize clinical trial dosing and mitigate cytokine release syndrome risks across its broad portfolio of 15 novel oncology assets.
